AEON vs IVZ · P/E 0.0, $8.6M cap vs rev $3.57B
AEON Biopharma, Inc. (AEON) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
AEON Biopharma, Inc. (AEON) is a biotechnology company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
AEON does not have a complete income-statement cache yet.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
AEON currently screens at market cap $8.6M and trailing P/E 0.0. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the AEON and IVZ stock pages for the full models.
Not investment advice.